Monthly Archives: April 2016

http://www.lslog.com/facing-a-new-assessment-of-kyprolis-amgen-castigates-cost-effectiveness-teams-methods/Facing a new assessment of Kyprolis, Amgen castigates cost-effectiveness team's methods

Facing a new assessment of Kyprolis, Amgen castigates cost-effectiveness team's methods

Facing a new assessment of Kyprolis, Amgen castigates cost-effectiveness team's methods Amgen has some problems with a nonprofit's cost-effectiveness assessment of its multiple myeloma med, Kyprolis–and the offending document hasn't even published […]

http://www.lslog.com/allergan-ushers-actuallyshecan-campaign-onto-tribeca-festival-screens/Allergan ushers #ActuallySheCan campaign onto Tribeca festival screens

Allergan ushers #ActuallySheCan campaign onto Tribeca festival screens

Allergan ushers #ActuallySheCan campaign onto Tribeca festival screens Allergan is taking its hashtag-heavy, emoji-laden female empowerment campaign, #ActuallySheCan, to the Tribeca Film Festival.  Source: Fierce Pharma Allergan ushers #ActuallySheCan campaign onto […]

http://www.lslog.com/stem-cells-offer-mixed-results-as-a-potential-replacement-for-ventricular-assist-in-heart-failure/Stem cells offer mixed results as a potential replacement for ventricular assist in heart failure

Stem cells offer mixed results as a potential replacement for ventricular assist in heart failure

Stem cells offer mixed results as a potential replacement for ventricular assist in heart failure Scientists from Cedars-Sinai Heart Institute reported on a study at the American College of Cardiology […]

http://www.lslog.com/va-partners-with-cambridge-startup-for-genomic-analysis-of-1-million-u-s-veterans/VA partners with Cambridge startup for genomic analysis of 1 million U.S. veterans

VA partners with Cambridge startup for genomic analysis of 1 million U.S. veterans

VA partners with Cambridge startup for genomic analysis of 1 million U.S. veterans Seven Bridges is on a roll. In February, the genomic analysis startup nabbed a $45 million Series […]

http://www.lslog.com/dont-worry-pfizer-and-allergan-treasury-just-did-you-a-favor/Don't worry, Pfizer and Allergan. Treasury just did you a favor

Don't worry, Pfizer and Allergan. Treasury just did you a favor

Don't worry, Pfizer and Allergan. Treasury just did you a favor Pfizer and Allergan may feel pained by the collapse of their $160 billion merger. But when the U.S. Treasury […]

http://www.lslog.com/startup-launches-device-for-early-detection-of-iv-tissue-infiltration-to-reduce-complications/Startup launches device for early detection of IV tissue infiltration to reduce complications

Startup launches device for early detection of IV tissue infiltration to reduce complications

Startup launches device for early detection of IV tissue infiltration to reduce complications Startup ivWatch was formed in December 2010 in an effort to create technology that would enable safer […]

http://www.lslog.com/verily-ceo-conrad-does-damage-control-in-light-of-managerial-attacks/Verily CEO Conrad does damage control in light of managerial attacks

Verily CEO Conrad does damage control in light of managerial attacks

Verily CEO Conrad does damage control in light of managerial attacks Verily CEO Andrew Conrad is doing damage control after an article last week said that he was driving away […]

http://www.lslog.com/astrazeneca-and-takeda-dpp-4-inhibitors-get-another-warning-added-to-their-labels/AstraZeneca and Takeda DPP-4 inhibitors get another warning added to their labels

AstraZeneca and Takeda DPP-4 inhibitors get another warning added to their labels

AstraZeneca and Takeda DPP-4 inhibitors get another warning added to their labels There is more bad news for DPP-4 inhibitor diabetes drugs saxagliptin and alogliptin from AstraZeneca and Takeda. The […]

http://www.lslog.com/can-celltrions-remicade-biosim-repeat-its-eu-market-share-steal-in-the-u-s/Can Celltrion's Remicade biosim repeat its EU market-share steal in the U.S.?

Can Celltrion's Remicade biosim repeat its EU market-share steal in the U.S.?

Can Celltrion's Remicade biosim repeat its EU market-share steal in the U.S.? The first Remicade biosimilar has won approval in the U.S.–and now it's time to see if it'll cause […]

http://www.lslog.com/more-injectables-capacity-in-the-us-germany/More injectables capacity in the US, Germany

More injectables capacity in the US, Germany

Novo Nordisk held a groundbreaking ceremony in Clayton, NC in late March to begin construction of a $1.8-billion expansion, roughly tripling the size of its manufacturing facilities there. The existing […]